DE3750544D1 - Antigen-spezifisches Entfernen von zirkulierenden Immunokomplexen. - Google Patents

Antigen-spezifisches Entfernen von zirkulierenden Immunokomplexen.

Info

Publication number
DE3750544D1
DE3750544D1 DE3750544T DE3750544T DE3750544D1 DE 3750544 D1 DE3750544 D1 DE 3750544D1 DE 3750544 T DE3750544 T DE 3750544T DE 3750544 T DE3750544 T DE 3750544T DE 3750544 D1 DE3750544 D1 DE 3750544D1
Authority
DE
Germany
Prior art keywords
antigens
blood
plasma
treated
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3750544T
Other languages
English (en)
Inventor
Frank R Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imre Corp
Original Assignee
Imre Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imre Corp filed Critical Imre Corp
Application granted granted Critical
Publication of DE3750544D1 publication Critical patent/DE3750544D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE3750544T 1986-11-21 1987-11-17 Antigen-spezifisches Entfernen von zirkulierenden Immunokomplexen. Expired - Lifetime DE3750544D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93370586A 1986-11-21 1986-11-21

Publications (1)

Publication Number Publication Date
DE3750544D1 true DE3750544D1 (de) 1994-10-20

Family

ID=25464384

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3750544T Expired - Lifetime DE3750544D1 (de) 1986-11-21 1987-11-17 Antigen-spezifisches Entfernen von zirkulierenden Immunokomplexen.

Country Status (5)

Country Link
EP (1) EP0272792B1 (de)
JP (1) JPS63212369A (de)
AT (1) ATE111358T1 (de)
CA (1) CA1337112C (de)
DE (1) DE3750544D1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078673A (en) * 1988-11-14 1992-01-07 Neorx Corporation Selective removal of radiolabeled antibodies
DE19538641C2 (de) * 1995-10-05 2000-09-21 Privates Inst Bioserv Gmbh Patientenspezifische Immunadsorber für die extrakorporale Apherese und Verfahren für deren Herstellung
FR2777355B1 (fr) * 1998-04-10 2000-05-12 Bio Merieux Procede de fixation d'une molecule biologique sur la surface d'un support constitue de silice ou d'oxyde metallique
CN1203805A (zh) * 1998-06-04 1999-01-06 李胤良 防治月经病证保健饮料
CN1209548A (zh) * 1998-06-08 1999-03-03 南开大学 碳化树脂dna免疫吸附剂的制备方法
CA2483551A1 (en) * 2002-04-26 2003-11-06 Wellstat Biologics Corporation Immunogenic agent therapy using plasmapheresis or exchange transfusion
AU2003903317A0 (en) * 2003-06-27 2003-07-10 Proteome Systems Intellectual Property Pty Ltd Method of isolating a protein
JP5227271B2 (ja) * 2009-07-27 2013-07-03 旭化成メディカル株式会社 血液からウイルス及びサイトカインを除去するシステム
CN109289760B (zh) * 2018-11-30 2021-09-28 暨南大学 二氧化硅纳米粒子在dna免疫吸附剂中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1130228A (en) * 1980-05-21 1982-08-24 Chiang-Chang Liao Support matrix for amino-containing biologically active substances
JPS5777624A (en) * 1980-10-31 1982-05-15 Asahi Chem Ind Co Ltd Adsorbent for rheumatoid factor and apparatus for removing rheumatoid factor
JPS57103649A (en) * 1980-12-18 1982-06-28 Asahi Chemical Ind Sterilized gamma-globulin fixing column
JPS5896027A (ja) * 1981-12-02 1983-06-07 Teijin Ltd 免疫複合体の除去剤および除去方法
JPS58130044A (ja) * 1982-01-28 1983-08-03 帝人株式会社 免疫複合体の除去剤および除去方法
DE3376223D1 (en) * 1982-07-29 1988-05-11 Shimadzu Corp A bioreactor and a process for the production thereof
DK317483D0 (da) * 1983-07-08 1983-07-08 Superfos As Immobiliseret enzympraeparat og fremgangsmade til fremstilling deraf
JPS60246765A (ja) * 1984-05-22 1985-12-06 旭化成工業株式会社 体液浄化用吸着カラム
US4752569A (en) * 1984-06-21 1988-06-21 The Regents Of The University Of California Sialylated Lewisx epitope, antibodies and diagnosis
US4681870A (en) * 1985-01-11 1987-07-21 Imre Corporation Protein A-silica immunoadsorbent and process for its production

Also Published As

Publication number Publication date
EP0272792A1 (de) 1988-06-29
JPS63212369A (ja) 1988-09-05
CA1337112C (en) 1995-09-26
ATE111358T1 (de) 1994-09-15
EP0272792B1 (de) 1994-09-14

Similar Documents

Publication Publication Date Title
US4664913B1 (de)
ATE59146T1 (de) Geraet zur bestrahlung von blutteilen.
DK486588D0 (da) Konjungater af cytokininer med immunglobuliner
DE3684732D1 (de) Adoptivimmuntherapie als behandlungsmodalitaet bei menschen.
DE69334141D1 (de) Schweinevirus, Erreger der sich vermehrenden Erkrankung der Atemwege, Impstoffe und seine virale DNA
DE3382723D1 (de) Adsorbens und Verfahren zu dessen Herstellung.
DE3750544D1 (de) Antigen-spezifisches Entfernen von zirkulierenden Immunokomplexen.
NO902696D0 (no) Ny familie av modifiserte hoeyaffinitetsantistoff for kreftbehandling.
ATE407149T1 (de) Detoxifizierung durch intramuskulär verabreichte f(ab')2 fragmente
Foon et al. Posttransfusion hepatitis in acute myelogenous leukemia: Effect on survival
ATE64531T1 (de) Tumortherapeutikum und verfahren zu seiner herstellung.
Bensinger et al. Clinical trials with staphylococcal protein A
ATE65413T1 (de) Geraet zur aussenkoerperlichen behandlung von koerperlichen fluessigkeiten.
HUT75376A (en) T cell stimulating protein of pestivirus
HOSHI et al. Formation of lymph follicles in draining lymph nodes after local injection of various antigenic substances in mice
FI954127A0 (fi) Menetelmä C-hepatiitin hoitamiseksi interferonihoitoon reagoimattomissa potilaissa
FR2600256B1 (fr) Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus
Andersen et al. Treatment of psoriasis with plasmapheresis
Miller et al. Protein A adsorption of acute myelogenous leukemia serum induces in vitro blast lysis
SE8306384D0 (sv) Farmaceutisk komposition
Malkinson Acknowledgment of Secretarial Help in Archives Manuscripts-Reply
Stenzel et al. Prevention of Renal Failure and a New Look for the Journal of Dialysis
Georgadze et al. Development and testing of antistaphylococcal heterogenous gamma globulin.
MC1653A1 (fr) Antigene viral,son procede d'obtention et son application diagnostique et therapeutique
RU96117545A (ru) Способ лечения диабетической ретинопатии

Legal Events

Date Code Title Description
8332 No legal effect for de